The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface

Oncogene. 2002 Nov 7;21(51):7808-16. doi: 10.1038/sj.onc.1205885.

Abstract

During papillomavirus infection, the E5 protein localizes in the cell Golgi apparatus and other endomembrane compartments. Cells transformed by E5 do not express major histocompatibility class I complex (MHC I) on the cell surface, while cells transformed by the other transforming proteins E6 and E7 do. In addition, the total amount of both MHC I protein and mRNA is reduced in E5-transformed cells. Here we show that expression of bovine papillomavirus E5 causes the retention of MHC I in the Golgi apparatus, thus preventing its transport to the cell surface. We ascribe this effect to a failure of acidification of the Golgi apparatus, as similar effects are observed in control cells treated with the ionophore monensin. Treatment of E5-transformed cells with either beta- or gamma-interferon increases the synthesis of MHC I, showing that inhibition of MHC I expression by E5 is not irreversible. However, even after interferon treatment, MHC I, although increased in quantity, is not transported to the cell surface. E5 therefore affects MHC I at several levels, but prevention of MHC I transport to the cell surface appears to be the dominant effect. Lack of surface MHC I would have profound consequences for presentation of viral peptides to the immune system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Bovine papillomavirus 1 / drug effects
  • Bovine papillomavirus 1 / physiology*
  • Cattle
  • Cell Transformation, Viral
  • Gene Expression Regulation / drug effects
  • Genes, MHC Class I
  • Genes, Reporter
  • Golgi Apparatus / metabolism*
  • Green Fluorescent Proteins
  • Histocompatibility Antigens Class I / metabolism*
  • Hydrogen-Ion Concentration
  • Interferon-beta / pharmacology
  • Interferon-gamma / pharmacology
  • Ionophores / pharmacology
  • Luminescent Proteins / genetics
  • Luminescent Proteins / metabolism
  • Monensin / pharmacology
  • Oncogene Proteins, Viral / physiology*
  • Protein Transport / drug effects
  • Protein Transport / physiology*
  • RNA, Messenger / biosynthesis
  • Recombinant Fusion Proteins / metabolism
  • Viral Proteins / physiology

Substances

  • Antiviral Agents
  • E7 protein, Bovine papillomavirus type 4
  • Histocompatibility Antigens Class I
  • Ionophores
  • Luminescent Proteins
  • Oncogene Proteins, Viral
  • RNA, Messenger
  • Recombinant Fusion Proteins
  • Viral Proteins
  • oncogene protein E5, Bovine papillomavirus type 1
  • oncogene protein E7, Bovine papillomavirus type 1
  • protein E6, Bovine papillomavirus
  • Green Fluorescent Proteins
  • Interferon-beta
  • Interferon-gamma
  • Monensin